Saturday 17 October 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024. In the quarter to June 2026, revenue fell 97.6%, EPS fell 800.0%, free cash flow fell 154.1% and total debt fell 8.32%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

1.52 0.13 −7.88%

Follow LXRX

Alert me

Market cap: $734.2M
P/E: 0.0×
Fwd P/E: −12.1×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	4	4	2
ROE Full definition →		(45.92%)	(39.72%)	(16.01%)	(40.21%)
ROA Full definition →		(26.02%)	(20.83%)	(9.21%)	(25.70%)
ROIC Full definition →		(68.83%)	(46.81%)	(18.49%)	(96.36%)
Return on Tangible Assets Full definition →		(66.72%)	(60.73%)	(14.67%)	(33.30%)
Average Days of Receivables Full definition →		12.02	17.47	61.73	14.46
Free Cash Flow per Share Full definition →		(0.20)	(0.19)	(0.10)	(0.15)
Free Cash Flow Full definition →		(72.11)	(67.85)	(38.80)	(64.99)
Other line items
Cash ROIC Full definition →		(24.64%)	(26.32%)	(9.17%)	(15.60%)
Accounts Receivable Turnover Full definition →		27.10	17.01	2.35	21.68
Accounts Payable Turnover Full definition →		0.05	0.03	0.05	0.09
Inventory Turnover Full definition →		1.06	1.07	1.48	0.52
Average Days of Payables Full definition →		3,291.94	4,106.92	3,106.65	2,388.81
Days of Inventory on Hand Full definition →		136.98	374.32	286.19	1,219.39
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		107.94%	122.73%	84.11%	145.34%
Selling, General and Administrative Expense of Revenue Full definition →		85.82%	74.93%	50.18%	85.23%
Share Based Compensation of Revenue Full definition →		15.83%	25.13%	18.02%	30.61%
Interest Coverage Full definition →		(6.58)	(5.87)	(2.99)	(6.50)
Operating CF/Net income Full definition →		1.05	1.35	1.49	1.06
Depreciation/Fixed assets Full definition →		1.13	1.25	1.45	1.57
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.20	0.14	0.17	0.09
Operating CF per Share Full definition →		(0.20)	(0.19)	(0.10)	(0.15)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly